Clinical Trials Browser

Phase 2 × Completed × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT04717154 2026-01-06

INSPIRE

Phase 2 Completed

Prostatic Neoplasms, Castration-Resistant

NCT03248570 2024-11-20

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Phase 2 Completed

26 enrolled 18 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant